226 related articles for article (PubMed ID: 11290811)
21. Tolerance to rat liver allografts. III. Donor cell migration and tolerance-associated cytokine production in peripheral lymphoid tissues.
Bishop GA; Sun J; DeCruz DJ; Rokahr KL; Sedgwick JD; Sheil AG; Gallagher ND; McCaughan GW
J Immunol; 1996 Jun; 156(12):4925-31. PubMed ID: 8648143
[TBL] [Abstract][Full Text] [Related]
22. Relative contribution of direct and indirect allorecognition in developing tolerance after liver transplantation.
Toyokawa H; Nakao A; Bailey RJ; Nalesnik MA; Kaizu T; Lemoine JL; Ikeda A; Tomiyama K; Papworth GD; Huang L; Demetris AJ; Starzl TE; Murase N
Liver Transpl; 2008 Mar; 14(3):346-57. PubMed ID: 18306376
[TBL] [Abstract][Full Text] [Related]
23. Analysis of cellular events in hepatic allografts: donor progenitors induce intragraft chimerism.
Gassel HJ; Otto C; Klein I; Meyer D; Timmermann W; Steger U; Gasser M; Ulrichs K; Thiede A
Transpl Int; 2000; 13 Suppl 1():S465-70. PubMed ID: 11112055
[TBL] [Abstract][Full Text] [Related]
24. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
25. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo.
Yanagawa Y; Sugahara K; Kataoka H; Kawaguchi T; Masubuchi Y; Chiba K
J Immunol; 1998 Jun; 160(11):5493-9. PubMed ID: 9605152
[TBL] [Abstract][Full Text] [Related]
26. Posttransplant infusion of donor-specific blood induces immunological unresponsiveness in rat hepatic allografts.
Liang J; Yamaguchi Y; Matsuda T; Ohshiro H; Zhang JL; Okabe K; Matsumura F; Ishihara K; Uchino S; Mori K; Yamada S; Ogawa M
Transplantation; 2000 Nov; 70(9):1363-71. PubMed ID: 11087154
[TBL] [Abstract][Full Text] [Related]
27. Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance.
Zhou P; Szot GL; Guo Z; Kim O; He G; Wang J; Grusby MJ; Newell KA; Thistlethwaite JR; Bluestone JA; Alegre ML
J Immunol; 2000 Nov; 165(10):5580-7. PubMed ID: 11067913
[TBL] [Abstract][Full Text] [Related]
28. The presence of donor-reactive CD4 T cells in early-phase liver-induced tolerance in rats: analysis using donor passenger leukocytes from the recipient.
Hashimoto T; Yamaguchi J; Gu W; Kanematsu T
Transpl Immunol; 2006 Jan; 15(3):205-9. PubMed ID: 16431287
[TBL] [Abstract][Full Text] [Related]
29. Deletion of spontaneous rat liver allograft acceptance by donor irradiation.
Sun J; McCaughan GW; Gallagher ND; Sheil AG; Bishop GA
Transplantation; 1995 Aug; 60(3):233-6. PubMed ID: 7645034
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of acquired thymic unresponsiveness to renal allografts. Thymic recognition of immunodominant allo-MHC peptides induces peripheral T cell anergy.
Sayegh MH; Perico N; Gallon L; Imberti O; Hancock WW; Remuzzi G; Carpenter CB
Transplantation; 1994 Jul; 58(2):125-32. PubMed ID: 8042230
[TBL] [Abstract][Full Text] [Related]
31. Organ transplant specificity of tolerance to skin grafts with heart or kidney grafts plus nondepleting anti-CD4 monoclonal antibody (RIB 5/2) and intravenous donor alloantigen administration.
Otomo N; Margenthaler JA; Motoyama K; Arima T; Shimizu Y; Lehmann M; Flye MW
J Surg Res; 2001 Jun; 98(1):59-65. PubMed ID: 11368539
[TBL] [Abstract][Full Text] [Related]
32. Exhaustive differentiation of alloreactive CD8+ T cells: critical for determination of graft acceptance or rejection.
Steger U; Denecke C; Sawitzki B; Karim M; Jones ND; Wood KJ
Transplantation; 2008 May; 85(9):1339-47. PubMed ID: 18475193
[TBL] [Abstract][Full Text] [Related]
33. Donor-specific stimulation of peripheral blood mononuclear cells from recipients of orthotopic liver transplants is associated, in the absence of rejection, with type-2 cytokine production.
Chung SW; Yoshida EM; Cattral MS; Hu Y; Gorczynski RM
Immunol Lett; 1998 Sep; 63(2):91-6. PubMed ID: 9761370
[TBL] [Abstract][Full Text] [Related]
34. A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts.
Huang WH; Yan Y; De Boer B; Bishop GA; House AK
Transplantation; 2003 Feb; 75(3):368-74. PubMed ID: 12589161
[TBL] [Abstract][Full Text] [Related]
35. Acquired transplant tolerance.
Perico N; Remuzzi G
Int J Clin Lab Res; 1997; 27(3):165-77. PubMed ID: 9352379
[TBL] [Abstract][Full Text] [Related]
36. [Effects of portal venous administration with allogenic cells on renal allograft survival in the rat].
Hamashima T; Yoshimura N; Matsui S; Lee CJ; Oka T
Nihon Geka Gakkai Zasshi; 1989 Oct; 90(10):1752-7. PubMed ID: 2480516
[TBL] [Abstract][Full Text] [Related]
37. Prolongation of liver allograft survival by dendritic cells modified with NF-kappaB decoy oligodeoxynucleotides.
Xu MQ; Suo YP; Gong JP; Zhang MM; Yan LN
World J Gastroenterol; 2004 Aug; 10(16):2361-8. PubMed ID: 15285020
[TBL] [Abstract][Full Text] [Related]
38. Combined donor leucocyte administration and immunosuppressive drug treatment for survival of rat heart allografts.
den Dulk M; Wang C; Li J; Clark DA; Hibberd AD; Terpstra OT; McCaughan GW; Bishop GA
Transpl Immunol; 2004 Nov; 13(3):177-84. PubMed ID: 15381200
[TBL] [Abstract][Full Text] [Related]
39. Anti-LFA-1 therapy induces long-term islet allograft acceptance in the absence of IFN-gamma or IL-4.
Nicolls MR; Coulombe M; Yang H; Bolwerk A; Gill RG
J Immunol; 2000 Apr; 164(7):3627-34. PubMed ID: 10725719
[TBL] [Abstract][Full Text] [Related]
40. Protection of heart and rejection of lymphocyte allografts from the same donor in recipients of donor-specific transfusions.
Jaskłowska-Englisz M; Olszewski WL; Maksymowicz M; Ziółkowska A
Ann Transplant; 1998; 3(1):28-33. PubMed ID: 9869895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
